Literature DB >> 25703837

Visceral white adipose tissue is susceptible to alcohol-induced lipodystrophy in rats: role of acetaldehyde.

Wenliang Zhang1, Wei Zhong, Xiuhua Sun, Qian Sun, Xiaobing Tan, Qiong Li, Xinguo Sun, Zhanxiang Zhou.   

Abstract

BACKGROUND: Chronic alcohol exposure causes lipid dyshomeostasis at the adipose-liver axis, reducing lipid storage in white fat and increasing lipid deposit in the liver. Previous studies have shown that visceral fat, rather than subcutaneous fat, is a risk factor for metabolic diseases. This study was conducted to determine whether chronic alcohol exposure differentially affects lipid metabolism in visceral (epididymal) and subcutaneous fat, and the mechanisms underlying the alcohol effects.
METHODS: Male Wistar rats were pair-fed the Lieber-DeCarli control or alcohol liquid diet for 12 weeks to determine the effects of alcohol on the white fat. Tissue explants culture and 3T3-L1 culture were conducted to define the role of acetaldehyde in alcohol-induced adipose tissue dysfunction.
RESULTS: Chronic alcohol feeding significantly reduced visceral fat mass and down-regulated peroxisome proliferator activator receptor-γ and CCAAT/enhancer binding protein-α, 2 important transcription factors in regulation of lipogenesis. The protein levels of lipogenic enzymes including phospho-ATP-citrate lyase, acetyl-CoA carboxylase, fatty acid synthase, lipin1, and diacylglycerol acyltransferase 2 in the visceral fat were reduced. In contrast, chronic alcohol exposure did not affect subcutaneous fat mass and had less effect on the protein levels of lipogenic enzymes and regulators. Accordingly, the visceral fat showed a lower protein level of aldehyde detoxification enzymes compared to the subcutaneous fat. Acetaldehyde treatment to either visceral fat explants or 3T3-L1 adipocytes produced similar effects on lipogenic enzymes and regulators as observed in animal model.
CONCLUSIONS: These results demonstrated that visceral fat is more susceptible to alcohol toxicity compared to subcutaneous fat, and disruption of adipose lipogenesis contributes to the pathogenesis of alcoholic lipodystrophy.
Copyright © 2015 by the Research Society on Alcoholism.

Entities:  

Keywords:  Alcohol; Lipid Dyshomeostasis; Lipogenesis; Subcutaneous Fat; Visceral Fat; White Adipose Tissue

Mesh:

Substances:

Year:  2015        PMID: 25703837      PMCID: PMC5896300          DOI: 10.1111/acer.12646

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  38 in total

Review 1.  Ectopic fat depots and cardiovascular disease.

Authors:  Kathryn A Britton; Caroline S Fox
Journal:  Circulation       Date:  2011-12-13       Impact factor: 29.690

2.  Human aldehyde dehydrogenase 3A1 (ALDH3A1): biochemical characterization and immunohistochemical localization in the cornea.

Authors:  Aglaia Pappa; Tia Estey; Rizwan Manzer; Donald Brown; Vasilis Vasiliou
Journal:  Biochem J       Date:  2003-12-15       Impact factor: 3.857

3.  Energy expenditure, substrate oxidation, and body composition in subjects with chronic alcoholism: new findings from metabolic assessment.

Authors:  G Addolorato; E Capristo; A V Greco; G F Stefanini; G Gasbarrini
Journal:  Alcohol Clin Exp Res       Date:  1997-09       Impact factor: 3.455

4.  Aldehyde dehydrogenase 1B1: molecular cloning and characterization of a novel mitochondrial acetaldehyde-metabolizing enzyme.

Authors:  Dimitrios Stagos; Ying Chen; Chad Brocker; Elizabeth Donald; Brian C Jackson; David J Orlicky; David C Thompson; Vasilis Vasiliou
Journal:  Drug Metab Dispos       Date:  2010-07-08       Impact factor: 3.922

Review 5.  The transcriptional basis of adipocyte development.

Authors:  Evan D Rosen
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2005-07       Impact factor: 4.006

6.  Chronic alcohol exposure stimulates adipose tissue lipolysis in mice: role of reverse triglyceride transport in the pathogenesis of alcoholic steatosis.

Authors:  Wei Zhong; Yantao Zhao; Yunan Tang; Xiaoli Wei; Xue Shi; Wenlong Sun; Xiuhua Sun; Xinmin Yin; Xinguo Sun; Seongho Kim; Craig J McClain; Xiang Zhang; Zhanxiang Zhou
Journal:  Am J Pathol       Date:  2012-01-09       Impact factor: 4.307

7.  Adipose triglyceride lipase: function, regulation by insulin, and comparison with adiponutrin.

Authors:  Erin E Kershaw; Jonathan K Hamm; Linda A W Verhagen; Odile Peroni; Masa Katic; Jeffrey S Flier
Journal:  Diabetes       Date:  2006-01       Impact factor: 9.461

8.  Taurine supplementation prevents ethanol-induced decrease in serum adiponectin and reduces hepatic steatosis in rats.

Authors:  Xiaocong Chen; Becky M Sebastian; Hui Tang; Megan M McMullen; Armend Axhemi; Donald W Jacobsen; Laura E Nagy
Journal:  Hepatology       Date:  2009-05       Impact factor: 17.425

9.  A meta-analysis of alcohol consumption and the risk of 15 diseases.

Authors:  Giovanni Corrao; Vincenzo Bagnardi; Antonella Zambon; Carlo La Vecchia
Journal:  Prev Med       Date:  2004-05       Impact factor: 4.018

10.  Chronic ethanol and triglyceride turnover in white adipose tissue in rats: inhibition of the anti-lipolytic action of insulin after chronic ethanol contributes to increased triglyceride degradation.

Authors:  Li Kang; Xiaocong Chen; Becky M Sebastian; Brian T Pratt; Ilya R Bederman; James C Alexander; Stephen F Previs; Laura E Nagy
Journal:  J Biol Chem       Date:  2007-08-07       Impact factor: 5.157

View more
  17 in total

Review 1.  Physiological processes underlying organ injury in alcohol abuse.

Authors:  Flavia M Souza-Smith; Charles H Lang; Laura E Nagy; Shannon M Bailey; Loren H Parsons; Gary J Murray
Journal:  Am J Physiol Endocrinol Metab       Date:  2016-07-19       Impact factor: 4.310

2.  Adipose tissue-liver axis in alcoholic liver disease.

Authors:  Zhi-Gang Wang; Xiao-Bing Dou; Zhan-Xiang Zhou; Zhen-Yuan Song
Journal:  World J Gastrointest Pathophysiol       Date:  2016-02-15

Review 3.  Lipid droplet-associated proteins in alcoholic liver disease: a potential linkage with hepatocellular damage.

Authors:  Yoshihiro Ikura; Stephen H Caldwell
Journal:  Int J Clin Exp Pathol       Date:  2015-08-01

4.  Alcohol intake and the risk of osteonecrosis of the femoral head in Japanese populations: a dose-response meta-analysis of case-control studies.

Authors:  Byung-Ho Yoon; Tae-Young Kim; In-Soo Shin; Hee Young Lee; Yun Jong Lee; Kyung-Hoi Koo
Journal:  Clin Rheumatol       Date:  2017-07-06       Impact factor: 2.980

Review 5.  Alcoholic liver disease: a new insight into the pathogenesis of liver disease.

Authors:  Seol Hee Park; Young-Sun Lee; Jaemin Sim; Seonkyung Seo; Wonhyo Seo
Journal:  Arch Pharm Res       Date:  2022-06-27       Impact factor: 6.010

Review 6.  A review of the role of ethanol-induced adipose tissue dysfunction in alcohol-associated liver disease.

Authors:  Thiyagarajan Gopal; Weilun Ai; Carol A Casey; Terrence M Donohue; Viswanathan Saraswathi
Journal:  Alcohol Clin Exp Res       Date:  2021-09-23       Impact factor: 3.928

7.  Decreased Whole-Body Fat Mass Produced by Chronic Alcohol Consumption is Associated with Activation of S6K1-Mediated Protein Synthesis and Increased Autophagy in Epididymal White Adipose Tissue.

Authors:  Kristen T Crowell; Jennifer L Steiner; Catherine S Coleman; Charles H Lang
Journal:  Alcohol Clin Exp Res       Date:  2016-07-27       Impact factor: 3.455

8.  Hepatic Peroxisome Proliferator-Activated Receptor Gamma Signaling Contributes to Alcohol-Induced Hepatic Steatosis and Inflammation in Mice.

Authors:  Wenliang Zhang; Qian Sun; Wei Zhong; Xinguo Sun; Zhanxiang Zhou
Journal:  Alcohol Clin Exp Res       Date:  2016-04-08       Impact factor: 3.455

9.  Adipose tissue autophagy and homeostasis in alcohol-induced liver injury.

Authors:  Yuan Li; Wen-Xing Ding
Journal:  Liver Res       Date:  2017-04-26

10.  Defect of mitochondrial respiratory chain is a mechanism of ROS overproduction in a rat model of alcoholic liver disease: role of zinc deficiency.

Authors:  Qian Sun; Wei Zhong; Wenliang Zhang; Zhanxiang Zhou
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-11-19       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.